WILLIAM W REED
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology NORFOLK, VA NPI 1790784767
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology VA Amgen Inc. All categories
General Payments — all program years on this page
$9,329.42
- Category: General Payments
- Program years: PY2018–2023
- Record count: 519
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $1,317.78 across 66 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,298.09 | 65 |
| Education | $19.69 | 1 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $180.94 | 11 |
| Lilly USA, LLC | $171.68 | 10 |
| Novo Nordisk AS | $147.87 | 9 |
| Acerta Pharma LLC | $141.97 | 8 |
| EXACTECH, INC. | $114.00 | 1 |
| ABBVIE INC. | $80.80 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $65.59 | 3 |
| PFIZER INC. | $63.48 | 3 |
| Merck Sharp & Dohme Corporation | $63.27 | 4 |
| Genentech USA, Inc. | $49.24 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $47.10 | 2 |
| Aurinia Pharma U.S., Inc. | $36.51 | 2 |
| Mallinckrodt Hospital Products Inc. | $26.40 | 1 |
| Radius Health, Inc. | $26.32 | 1 |
| Actelion Pharmaceuticals US, Inc. | $23.28 | 1 |
| Janssen Biotech, Inc. | $21.31 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.00 | 1 |
| Alexion Pharmaceuticals, Inc. | $19.92 | 1 |
| Ultragenyx Pharmaceutical Inc. | $17.10 | 1 |
By program year
Records — PY2023 (66)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.